The innovative biotech firm based in Vienna.

The scholarly study will be completed at the Medical University of Vienna. With this step, AVIR Green Hills offers set yet another essential milestone in the advancement of effective and modern influenza vaccines. Start of clinical phase II study In a randomized double blind study, the vaccine will be administered to 48 volunteers intranasally. ‘In double blind studies, neither the administering physician nor the volunteers understand who gets the placebo. Moreover, non-e of these knows which sprays support the tested vaccine and that have the placebo,’ explains Franz Groiss, who is in charge of managing clinical studies at AVIR Green Hills Biotechnology.

Pascale Barberger-Gateau, M.D., Ph.D. Of Inserm U593 , and Dr. Bernadette Allinquant, Ph.D. Of center Paul Broca . The Bordeaux research team will receive 40,000 euros for one yr and the Paris group offers been awarded a one-year grant for 40,000 euros. Furthermore, in 2007 AIRMA awarded a special fund to Dr. Since its inception in May 2003, AIRMA offers awarded a lot more than 450,000 euros to analyze teams in France. Among the organizations awarded previously are INSERM U422 , INSERM U573 , INSERM U593 , Institut Pasteur , Inserm U661 and University of Poitiers, medical school ..Pascale Barberger-Gateau, M.D., Ph.D. Of Inserm U593 , and Dr. Bernadette Allinquant, Ph.D. Of center Paul Broca . The Bordeaux research team will receive 40,000 euros for one yr and the Paris group offers been awarded a one-year grant for 40,000 euros. Furthermore, in 2007 AIRMA awarded a special fund to Dr. Since its inception in May 2003, AIRMA offers awarded a lot more than 450,000 euros to analyze teams in France. Among the organizations awarded previously are INSERM U422 , INSERM U573 , INSERM U593 , Institut Pasteur , Inserm U661 and University of Poitiers, medical school ..